246 related articles for article (PubMed ID: 37644281)
1. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
2. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients.
Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB
BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885
[TBL] [Abstract][Full Text] [Related]
3. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
[TBL] [Abstract][Full Text] [Related]
4. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
5. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
6. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
Myers KV; Amend SR; Pienta KJ
Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment.
Cruz Cruz J; Allison KC; Page LS; Jenkins AJ; Wang X; Earp HS; Frye SV; Graham DK; Verneris MR; Lee-Sherick AB
Front Immunol; 2023; 14():1146721. PubMed ID: 36960055
[TBL] [Abstract][Full Text] [Related]
8. Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization.
Zizzo G; Cohen PL
Inflammation; 2018 Dec; 41(6):2206-2221. PubMed ID: 30091033
[TBL] [Abstract][Full Text] [Related]
9. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
[TBL] [Abstract][Full Text] [Related]
10. Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.
Soki FN; Koh AJ; Jones JD; Kim YW; Dai J; Keller ET; Pienta KJ; Atabai K; Roca H; McCauley LK
J Biol Chem; 2014 Aug; 289(35):24560-72. PubMed ID: 25006249
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
She Y; Xu X; Yu Q; Yang X; He J; Tang XX
Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
[TBL] [Abstract][Full Text] [Related]
12. MERTK
Junior ; Lai YS; Nguyen HT; Salmanida FP; Chang KT
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638941
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
[TBL] [Abstract][Full Text] [Related]
15. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
[TBL] [Abstract][Full Text] [Related]
16. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
17. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies.
Bravo DD; Shi Y; Sheu A; Liang WC; Lin W; Wu Y; Yan M; Wang J
J Immunol; 2023 Apr; 210(8):1166-1176. PubMed ID: 36881873
[TBL] [Abstract][Full Text] [Related]
18. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
[TBL] [Abstract][Full Text] [Related]
19. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.
Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z
Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649
[No Abstract] [Full Text] [Related]
20. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.
Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T
J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
